UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Joined analysis of sarcomatoid carcinoma (SC) mutational profiles: Comparison of lung versus head and neck cancer

Annals of oncology, 2018-10, Vol.29, p.viii671-viii671

2018

Volltextzugriff (PDF)

468 Validity of next generation sequencing in routine care for non-small cell lung cancer diagnosis

European journal of cancer (1990), 2015-09, Vol.51, p.S101-S102

2015

Volltextzugriff (PDF)

208 Different prognostic impact of STK11 mutations in Non-Small-Cell Lung Cancer (NSCLC) illustrates the switch from a tumor suppressor to an oncogene

European journal of cancer (1990), 2015-09, Vol.51, p.S29-S30

2015

Volltextzugriff (PDF)

Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma

Annals of oncology, 2013-12, Vol.24 (12), p.2963-2967

2013

Volltextzugriff (PDF)

Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities

Annals of oncology, 2017-07, Vol.28 (7), p.1597-1604

2017

Volltextzugriff (PDF)

Sorafenib in advanced melanoma: a critical role for pharmacokinetics?

British journal of cancer, 2012-07, Vol.107 (3), p.455-461

2012

Volltextzugriff (PDF)

Implications d'ALK (anaplastic lymphoma kinase) en oncohématologie

Bulletin du cancer, 2010-08, Vol.97 (8), p.991-996

2010

Volltextzugriff (PDF)

Inhibiteurs des histone-désacétylases : la régulation épigénétique sort de l’ombre

Bulletin du cancer, 2010-08, Vol.97 (8), p.917-935

2010

Volltextzugriff (PDF)

Histone deacetylase inhibitors: highlight on epigenetic regulation

Bulletin du cancer, 2010-08, Vol.97 (8), p.917

2010

Volltextzugriff (PDF)

Implications of ALK (anaplastic lymphoma kinase) in oncohematology

Bulletin du cancer, 2010-08, Vol.97 (8), p.991

2010

Volltextzugriff (PDF)

724P A prospective phase II study of gemcitabine plus platinum in combination with bevacizumab for metastatic renal medullary and collecting duct carcinoma (GETUG-AFU 24, BEVABEL trial)

Annals of oncology, 2020-09, Vol.31, p.S568-S568

2020

Volltextzugriff (PDF)

1896PDJoined analysis of sarcomatoid carcinoma (SC) mutational profiles: Comparison of lung versus head and neck cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts)

Annals of oncology, 2016-10, Vol.27, p.vi29-vi29

2016

Volltextzugriff (PDF)

Plasmatic Tumor Dna Assessments Predict Clinical Outcome in Egfr-Mutated Non-Small Cell Lung Cancer Patients Treated By Egfr Inhibitors

Annals of oncology, 2014-09, Vol.25, p.iv450

2014

Volltextzugriff (PDF)

1280PPLASMATIC TUMOR DNA ASSESSMENTS PREDICT CLINICAL OUTCOME IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER PATIENTS TREATED BY EGFR INHIBITORS

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv450-iv451

2014

Volltextzugriff (PDF)

Intensité de dose dans le traitement du cancer du sein

Oncologie (Paris, France), 2007-12, Vol.9 (12), p.814-820

2007

Volltextzugriff (PDF)

292PRADIOLOGICAL-HISTOLOGICAL SIZE CORRELATION IN TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv97-iv98

2014

Volltextzugriff (PDF)

Radiological-Histological Size Correlation in Triple-Negative Breast Cancer (Tnbc)

Annals of oncology, 2014-09, Vol.25, p.iv97

2014

Volltextzugriff (PDF)

IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?

Revue de pneumologie clinique, 2018-10, Vol.74 (5), p.327-338

2018

Volltextzugriff (PDF)

Intensité de dose dans le traitement du cancer du sein : Greffes et Cancer

Oncologie (Paris, France), 2007, Vol.9 (12), p.814-820

2007

Volltextzugriff (PDF)

Crizotinib in Patients with Lung Cancer and Ros1 Fusion: Results from the European Cohort Euros1

Annals of oncology, 2014-09, Vol.25, p.iv457

2014

Volltextzugriff (PDF)

939TiPRANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED PHASE II TRIAL OF NINTEDANIB VERSUS PLACEBO IN ADVANCED OVARIAN CANCER (OC) PATIENTS TREATED WITH NEO-ADJUVANT CHEMOTHERAPY (NACX) AND INTERVAL DEBULKING SURGERY (IDS):THE CHIVA TRIAL FROM GINECO

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv324-iv324

2014

Volltextzugriff (PDF)

1298PCRIZOTINIB IN PATIENTS WITH LUNG CANCER AND ROS1 FUSION: RESULTS FROM THE EUROPEAN COHORT EUROS1

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv457-iv458

2014

Volltextzugriff (PDF)

Randomized Double Blind Placebo-Controlled Phase Ii Trial of Nintedanib Versus Placebo in Advanced Ovarian Cancer (Oc) Patients Treated with Neo-Adjuvant Chemotherapy (Nacx) and Interval Debulking Surgery (Ids):The Chiva Trial from Gineco

Annals of oncology, 2014-09, Vol.25, p.iv324

2014

Volltextzugriff (PDF)

IHC, FISH, CISH, NGS dans les cancers bronchiques non à petites cellules : quelles évolutions dans l’ère des biomarqueurs ?

Revue de pneumologie clinique, 2018-10, Vol.74 (5), p.327-338

2018

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(28)
Französisch
(23)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Joined analysis of sarcomatoid carcinoma (SC) mutational profiles: Comparison of lung versus head and neck cancer

468 Validity of next generation sequencing in routine care for non-small cell lung cancer diagnosis

208 Different prognostic impact of STK11 mutations in Non-Small-Cell Lung Cancer (NSCLC) illustrates the switch from a tumor suppressor to an oncogene

Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma

Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities

Sorafenib in advanced melanoma: a critical role for pharmacokinetics?

Implications d'ALK (anaplastic lymphoma kinase) en oncohématologie

Inhibiteurs des histone-désacétylases : la régulation épigénétique sort de l’ombre

Histone deacetylase inhibitors: highlight on epigenetic regulation

Implications of ALK (anaplastic lymphoma kinase) in oncohematology

724P A prospective phase II study of gemcitabine plus platinum in combination with bevacizumab for metastatic renal medullary and collecting duct carcinoma (GETUG-AFU 24, BEVABEL trial)

1896PDJoined analysis of sarcomatoid carcinoma (SC) mutational profiles: Comparison of lung versus head and neck cancer

Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts)

Plasmatic Tumor Dna Assessments Predict Clinical Outcome in Egfr-Mutated Non-Small Cell Lung Cancer Patients Treated By Egfr Inhibitors

1280PPLASMATIC TUMOR DNA ASSESSMENTS PREDICT CLINICAL OUTCOME IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER PATIENTS TREATED BY EGFR INHIBITORS

Intensité de dose dans le traitement du cancer du sein

292PRADIOLOGICAL-HISTOLOGICAL SIZE CORRELATION IN TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Radiological-Histological Size Correlation in Triple-Negative Breast Cancer (Tnbc)

IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?

Intensité de dose dans le traitement du cancer du sein : Greffes et Cancer

Crizotinib in Patients with Lung Cancer and Ros1 Fusion: Results from the European Cohort Euros1

939TiPRANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED PHASE II TRIAL OF NINTEDANIB VERSUS PLACEBO IN ADVANCED OVARIAN CANCER (OC) PATIENTS TREATED WITH NEO-ADJUVANT CHEMOTHERAPY (NACX) AND INTERVAL DEBULKING SURGERY (IDS):THE CHIVA TRIAL FROM GINECO

1298PCRIZOTINIB IN PATIENTS WITH LUNG CANCER AND ROS1 FUSION: RESULTS FROM THE EUROPEAN COHORT EUROS1

Randomized Double Blind Placebo-Controlled Phase Ii Trial of Nintedanib Versus Placebo in Advanced Ovarian Cancer (Oc) Patients Treated with Neo-Adjuvant Chemotherapy (Nacx) and Interval Debulking Surgery (Ids):The Chiva Trial from Gineco

IHC, FISH, CISH, NGS dans les cancers bronchiques non à petites cellules : quelles évolutions dans l’ère des biomarqueurs ?

Suchergebnisse filtern